NCT04933370 is a NA clinical trial of Stimulation parameters in Chronic Pain, sponsored by Alberta Health Services, Calgary.

Who is sponsoring NCT04933370?

NCT04933370 is sponsored by Alberta Health Services, Calgary.

What drugs are being tested in NCT04933370?

Interventions in NCT04933370: Stimulation parameters.

What condition does NCT04933370 study?

NCT04933370 studies Chronic Pain.

Is NCT04933370 still recruiting?

NCT04933370 is currently recruiting now. Last updated 7 August 2024.

Last reviewed 2024-08-07 · How we verify

NCT04933370

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuromodulation Parameter Efficacy

Recruiting now NA Last updated 7 August 2024

What this trial tests

NA trial testing Stimulation parameters in Chronic Pain in 20 participants. Currently enrolling.

Timeline

1 February 2022

Primary endpoint
1 July 2026

1 July 2026

Quick facts

Lead sponsor	Alberta Health Services, Calgary
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	20
Start date	1 February 2022
Primary completion	1 July 2026
Estimated completion	1 July 2026
Sites	1 location across Canada

Drugs / interventions tested

Stimulation parameters

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

Alberta Health Services, Calgary

Who can join

Adults 18 to 100, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to determine the efficacy of neuromodulation using various stimulation paradigms in the treatment of several disorders including chronic pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Alberta Health Services, Calgary trials

Trials by the same sponsor.

NCT04937010 — Occipital Nerve Stimulation in Trigeminal Autonomic Cephalgias · NA · recruiting
NCT04057872 — Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis · Phase 1 · completed
NCT03604809 — Guided Occupational Therapist Cognitive Interventions in Critically Ill Patients · NA · completed
NCT03456167 — Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery · NA · completed
NCT04339296 — Connected Healthcare for Individuals Living at Home With Chronic Conditions · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04933370 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alberta Health Services, Calgary
Last refreshed: 7 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04933370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing